Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.

Vitale A, Ramirez Morales R, dalla Bona E, Scopelliti M, Zanus G, Neri D, d'Amico F, Gringeri E, Russo F, Burra P, Angeli P, Cillo U.

Transplant Proc. 2011 May;43(4):974-6. doi: 10.1016/j.transproceed.2011.01.138.

PMID:
21620029
2.

Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.

Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group..

Am J Transplant. 2011 Dec;11(12):2724-36. doi: 10.1111/j.1600-6143.2011.03732.x. Epub 2011 Sep 15.

3.

Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.

Bambha KM, Dodge JL, Gralla J, Sprague D, Biggins SW.

Liver Transpl. 2015 Oct;21(10):1286-94. doi: 10.1002/lt.24188.

4.

The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW.

Liver Transpl. 2015 Aug;21(8):1022-30. doi: 10.1002/lt.24194.

5.

Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.

Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM.

Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):256-62.

6.

Renal outcomes after liver transplantation in the model for end-stage liver disease era.

Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS.

Liver Transpl. 2009 Sep;15(9):1142-8. doi: 10.1002/lt.21821.

7.

Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.

Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW.

Liver Transpl. 2015 Nov;21(11):1365-73. doi: 10.1002/lt.24138.

8.

Impact of MELD score implementation on liver allocation: experience at a Brazilian center.

da Silva Machado AG, de Medeiros Fleck A Jr, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.

Ann Hepatol. 2013 May-Jun;12(3):440-7.

9.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators..

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

10.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

11.

Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.

Rifai G, Anani A, Hanouneh IA, Mohamad B, Matloob A, Lopez R, Zein NN, Alkhouri N.

Transplant Proc. 2016 Dec;48(10):3362-3367. doi: 10.1016/j.transproceed.2016.08.044.

PMID:
27931582
12.

Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.

Croome KP, Marotta P, Wall WJ, Dale C, Levstik MA, Chandok N, Hernandez-Alejandro R.

Transplant Proc. 2012 Jun;44(5):1303-6. doi: 10.1016/j.transproceed.2012.01.115.

PMID:
22664005
13.

Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.

Dumitra S, Alabbad SI, Barkun JS, Dumitra TC, Coutsinos D, Metrakos PP, Hassanain M, Paraskevas S, Chaudhury P, Tchervenkov JI.

HPB (Oxford). 2013 Sep;15(9):724-31. doi: 10.1111/hpb.12041. Epub 2013 Mar 14.

14.

Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.

Lanini S, Nanni Costa A, Grossi PA, Procaccio F, Ricci A, Capobianchi MR, Terrault NA, Ippolito G.

Liver Int. 2016 Mar;36(3):410-7. doi: 10.1111/liv.12938. Epub 2015 Sep 21.

15.

Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.

Sharpton SR, Feng S, Hameed B, Yao F, Lai JC.

Transplantation. 2014 Sep 15;98(5):557-62. doi: 10.1097/TP.0000000000000090.

16.

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.

Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U; Liver Transplantation North Italy Transplant program (NITp) working group..

J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23. Erratum in: J Hepatol. 2014 Jun;60(6):1336. Multiple investigator names added.

PMID:
24161408
17.

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.

Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F; Liver Match Investigators..

Dig Liver Dis. 2011 Feb;43(2):155-64. doi: 10.1016/j.dld.2010.11.002. Epub 2010 Dec 24.

PMID:
21185796
18.

Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.

Schlansky B, Chen Y, Scott DL, Austin D, Naugler WE.

Liver Transpl. 2014 Sep;20(9):1045-56. doi: 10.1002/lt.23917. Epub 2014 Aug 4.

19.

D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.

Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.

Transplantation. 2014 Feb 27;97(4):457-62. doi: 10.1097/01.TP.0000435696.23525.d0.

PMID:
24531822
20.

Prognostic evaluation of the donor risk index among a prospective cohort of Italian patients undergoing liver transplantation.

Vitale A, D'Amico F, Gringeri E, Valmasoni M, Pauletto A, Bonsignore P, Bassi D, D'Amico FE, Polacco M, Burra P, Russo F, Angeli P, Poci C, Feltracco P, Romano A, Cillo U.

Transplant Proc. 2009 May;41(4):1096-8. doi: 10.1016/j.transproceed.2009.03.097.

PMID:
19460490

Supplemental Content

Support Center